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ABSTRACT
BCCTBbp (http://bioinformatics.breastcancertissue
bank.org) was initially developed as the data-mining
portal of the Breast Cancer Campaign Tissue Bank
(BCCTB), a vital resource of breast cancer tissue
for researchers to support and promote cutting-
edge research. BCCTBbp is dedicated to maximis-
ing research on patient tissues by initially stor-
ing genomics, methylomics, transcriptomics, pro-
teomics and microRNA data that has been mined
from the literature and linking to pathways and
mechanisms involved in breast cancer. Currently,
the portal holds 146 datasets comprising over 227
795 expression/genomic measurements from vari-
ous breast tissues (e.g. normal, malignant or benign
lesions), cell lines and body fluids. BCCTBbp can be
used to build on breast cancer knowledge and max-
imise the value of existing research. By recording a
large number of annotations on samples and stud-
ies, and linking to other databases, such as NCBI,
Ensembl and Reactome, a wide variety of different
investigations can be carried out. Additionally, BC-
CTBbp has a dedicated analytical layer allowing re-
searchers to further analyse stored datasets. A fu-
ture important role for BCCTBbp is to make available
all data generated on BCCTB tissues thus building
a valuable resource of information on the tissues in
BCCTB that will save repetition of experiments and
expand scientific knowledge.
INTRODUCTION
Breast carcinoma is the leading cause of cancer-related
death among women, accounting for 23% of total cancer
cases and 14% of cancer deaths (1). It is a heterogeneous dis-
ease presenting a variety of morphological features as well
as a range of genetic, epigenetic and transcriptomic alter-
ations (2).
Advances in research have resulted in a huge improve-
ment in the outcome for patients. However, breast cancer
still remains a major public health issue with only three ro-
bust biomarkers predicting its response to endocrine (oe-
strogen receptor and progesterone receptor) or biologi-
cal therapies (human epidermal growth factor receptor
2 (HER2)). Despite the definite benefit of administering
hormonally-targeted treatments, we still do not know why
some patients respond to these therapies while others either
do not respond or develop resistance, which has serious clin-
ical implications.
A wide scale review involving over 50 of the world’s lead-
ing breast cancer researchers highlighted the inaccessibil-
ity of tissue samples and materials as a major obstacle in
translating science into new treatments, with researchers
sometimes spending months tracking down suitable sam-
ples with well annotated clinical data (3). To fill this void
and create a vital resource of breast cancer tissue for re-
searchers across the UK and Ireland, the Breast Cancer
Campaign Tissue Bank (BCCTB) was established in 2010
as a unique collaboration between leading UK research in-
stitutions (http://www.breastcancertissuebank.org) (4).
Associated with the Tissue Bank is a powerful bioin-
formatics portal (BCCTBbp) dedicated to maximising re-
search on patient tissues. The BCCTBbp was developed us-
ing BioMart, a well established, freely available bioinfor-
matics data management framework (5) to provide mutual-
istic support to the Tissue Bank. The BCCTBbp functions
as an online literature-mining resource, permitting users to
examine and collate published breast cancer data from a sin-
gle portal. BCCTBbp currently stores data that has been
mined from the literature on genes, transcripts, proteins,
non-coding RNA and copy number events and links this
to pathways and mechanisms involved in breast cancer. It
has an integrated analytical layer to enable researchers not
only to mine but also to analyse breast cancer literature data
from multiple sources.
Seamless interoperability between the Tissue Bank and
the bioinformatics portal allows researchers to examine
published findings prior to applying for tissues. This com-
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plementarity between the clinical data and samples avail-
able from the Tissue Bank and the literature-derived exper-
iments provided by the BCCTBbp exemplify how biology
and bioinformatics can be used synergistically to maximise
research output. Also, in future the BCCTBbp will store
experimental results generated on BCCTB tissues to make
these available to the whole community. Each BCCTB sam-
ple will be linked to all its associated experimental findings
which will ensure that researchers will have access to maxi-
mal data for every sample of interest, thus optimising data
sharing opportunities while minimising duplication of ef-
fort. While already undoubtedly an invaluable resource, the
full potential of the symbiotic relationship between the Tis-
sue Bank and bioinformatics portal will become reality as
more experimental data from BCCTB-provided samples is
returned and stored alongside the corresponding clinical in-
formation.
Here we describe its current data content, query system
and analytical capabilities.
CONSTRUCTION AND DATA CONTENT
The aim of the portal is to store, mine and integrate diverse
breast cancer datasets to produce a comprehensive resource
for breast cancer scientists. In order to achieve this, we de-
signed a robust internal structure encompassing the details
of breast cancer publications, experimental setup, detailed
clinical annotations and also experimental findings. Inher-
ent to the portal is a BioMart-compatible MySQL database
that stores this information in two datasets:
(i) ‘Study Dataset’ contains information about the pub-
lished articles and details on the patients/clinical sam-
ples used in each experiment/publication.
(ii) ‘Gene Dataset’ collates data on the genes, transcripts,
proteins, probesets, miRNAs and other biological fea-
tures reported to be expressed/regulated/altered in
each specific experiment. The portal currently supports
expression, proteomics, miRNA, genomics and methy-
lation experimental data types, although the flexibility
of the portal design enables other experimental data
types to be easily added as required.
The articles to be included in the database are selected
by periodic PubMed searches as well as suggestions from
breast cancer scientists and peers. Data from the original
articles are then manually curated, reviewed for accuracy
and consistency and finally loaded into the database. An ex-
tensive controlled vocabulary is employed to record specific
details on the clinical samples used in each study (Supple-
mentary Table S1). This includes detailed information on
the provenance of samples including extraction and prepa-
ration methods; cellular components; sample type; ma-
lignant and benign lesions; molecular subtypes; immuno-
chemistry markers as well as chemotherapy and drug treat-
ments (where available). Gene identifiers are extracted from
each relevant publication and mapped to the Ensembl hu-
man gene annotation system (version 69). Genomic coordi-
nates are standardised to GRCh37/hg19 using the liftOver
tool from UCSC (6).
Currently, BCCTBbp contains manually curated breast
cancer data extracted from 83 published ‘omics’ stud-
ies comprising 146 datasets of which there are 104 tran-
scriptomics, 8 proteomics, 5 methylation, 11 miRNA and
18 genomics datasets. The database contains 227 795
expression/genomic measurements on 14 742 genes, 91 119
transcripts and 112 microRNAs in over 16 000 samples
representing various normal, benign and malignant tissues,
body fluids, cell lines and murine models under different
treatment conditions.
The BCCTBbp gene information is supplemented with
key annotations from Ensembl including genes, transcripts,
proteins, SNPs, genomic features, gene ontologies and
multi-species data. This expands the variety of queries that
can be performed and by utilisation of standard identifiers
enables joint queries with other relevant biological datasets
using BioMart data federation technology. To assess the
quality of data extracted from publications and also to pro-
vide a uniform view of findings, selected datasets have been
reanalysed using an in-house data analysis pipeline (7). Ob-
tained results have been included in BCCTBbp and are
made available through a dedicated analytical interface al-
lowing users to interrogate these datasets and run further
explorations.
DATA ACCESS
BCCTBbp provides a number of access routes to accommo-
date different user types from basic querying to more com-
plex data mining capabilities.
Advanced/BioMart query
The most comprehensive query mode is available through
an integrated MartView web interface. This provides a cus-
tomised web interface with a multitude of querying options
based on the extensive clinical and experimental parame-
ters represented in the database. It follows the conventional
BioMart set up of Filters and Attributes that will be famil-
iar to any user of the numerous BioMart resources available.
A simple query involves selecting one of the two BCCTBbp
datasets available, setting up Filters to restrict searches to
specific criteria, and choosing the Attributes to be included
in the results. Below we outline the two available datasets
for query with related Filters and Attributes.
(i) The BCCTB Bioinformatics Gene Data provides a
number of modules for querying and extracting data by
experiment/technology, publication/comparison as well as
numerous options based on the study/sample controlled vo-
cabulary. Further modules for transcriptomics, proteomics,
genomics and miRNA profiling are available and allow
users to seamlessly link datasets based on the genes re-
ported in an experiment. This provides a powerful way to
build up large queries to answer complex scientific ques-
tions. Additional filter options are included from external
data sources including KEGG pathways as well as gene in-
formation, chromosomal regions, gene ontology terms, ex-
pression, protein domains, multispecies queries and vari-
ations based on Ensembl data to provide a diverse range
of queries and export options. The user has the choice to
add multiple attributes from the module categories to the
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Figure 1. Accessing the BCCTBbp data through the MartView web query interface. In this first example our goal was to identify differentially regu-
lated genes in Infiltrating Lobular Carcinoma (ILC), related pathways and check if any of these genes appear in the Parker PAM 50 gene set. The
MartView interface can be accessed by following the ‘Advanced/BioMart Search’ button on the main bioinformatics portal web page (http://bioinformatics.
breastcancertissuebank.org). The query starts by choosing the ‘BCCTB Bioinformatics Portal’ from the ‘Choose Database’ drop-down selection in the right
panel. Users will be automatically directed to choose a dataset from the ‘Choose Dataset’ drop-down menu. (A) The ‘BCCTB Bioinformatics Gene Data’
dataset can be chosen from the dropdown menus. The left panel will refresh automatically displaying the ‘Filters’ and ‘Attributes’ nodes with their default
settings. The next step involves choosing the appropriate attributes and filters to restrict the query. Clicking on the ‘Filters’ or ‘Attributes’ nodes on the left
will display the related page on the right where ‘Filters’ or ‘Attributes’ are arranged into sections, which can be expanded/collapsed using the ‘+/−’ box. To
choose an attribute or a filter, users can simply click on the checkbox next to its description. A summary of the selected filters and attributes is automatically
displayed in the left panel. We will click on Filters in the left panel and then expand the ‘SELECT GENES FROM TRANSCRIPTOMICS PROFILING
EXPERIMENTS:’ section. From the rich list of possible options, we will select ‘Specimen histology’ then ‘ILC versus normal lobular’ from the related
list. Clicking on the ‘Count’ button in the tool bar at any time when constructing the query will return the number of genes satisfying the pre-selected
criteria. (B) Clicking on the Attributes tab in the left panel allows the user to select which attributes of the data will be returned in the results. On the right
panel, these are arranged into six modules for ‘Study Data’, ‘Features’, ‘Structures’, ‘Transcript Event’, ‘Homologs’, ‘Variation’ and ‘Sequences’. In order
to select the output content, the ‘Attributes’ node on the left needs to be clicked on and the attribute page on the right needs to be chosen. In this example
we are interested in exploring the de-regulated pathways. From the ‘Study Data’ attribute page, a selection is made of Pathway URL and Pathway name
options. Finally, pressing the results button on the top left of the page will produce a table containing the requested information (C). One can select the
option to download the results to a file at the top of the result page and export them using the ‘GO’ button. Again, there are options to change the format
(‘HTML’, ‘CSV’ for comma separated values, ‘TSV’ for tab separated values, ‘XLS’ for Excel, ‘ADF’ for array description format) and whether to make
the results unique. One can select a compressed file output and the query will run in the background to be downloaded later. One needs to provide an email
address to receive an URL in a notification email that allows the query results to be downloaded. There is an option to produce a Perl script to repeat the
query programmatically with BioMart Perl API. Due to the nature of the database and the one-to-many relationship between genes and transcripts, some
results may appear more than once. To address that there is a button that can be used to present only unique results and the transcript attribute could be
removed from the final results.
data before the results are either displayed via the web in-
terface or exported in csv, excel or other formats. A fur-
ther BioMart feature is the ability to merge this output
data with other datasets such as UniProt, Reactome and
other relevant datasets through the BioMart central portal
(www.biomart.org).
A typical query is shown in Figure 1 where we can inves-
tigate differences in specimen histological types using the
transcriptomics profiling module. Here we investigate the
differences between Invasive Lobular Carcinoma (ILC) and
normal lobular cells and obtain a list of 175 transcripts of
significance and related pathways (Figure 1). The portal al-
lows multiple further filtering to enhance this initial query
if required. For example, we can intersect this output to see
if any of these genes appear in the Parker PAM 50 gene set
(17) and extract related upstream sequences (Supplemen-
tary Figure S1).
Supplementary Figure S2 shows how it is possible to
combine data from genomics and transcriptomics experi-
ments and perform more complex queries. Here we look for
potential genes of importance in basal breast cancer sub-
types. The flexibility of BioMart then allows the output to
be combined with different data types such as gene infor-
mation, study data and/or relevant pathways.
(ii) The BCCTB Bionformatics Study Data provides a
quick look up of clinical data from all studies in the
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Figure 2. Accessing the BCCTBbp data through the BCCTB Sample Finder. The BCCTB sample finder (https://breastcancertissuebank.org/bcc/
tissueBank?Name=sampleFinder, described elsewhere, manuscript in peer-review) is used to find samples within the Tissue Bank matching character-
istics of interest. Here the Sample Finder is used to retrieve ILC samples available from BCCTB. On the lower left corner, the bioinformatics section
indicates 18 studies stored in the BCCTBbp with ILC samples. Clicking on the hyperlink ‘View details’ will produce a detailed list of these studies, with
PubMed and GEO links (where available), as well as the number of the total samples in each of the datasets. Users could then choose to go to the main
BCCTBbp to mine the results published on these samples (see Figure 1).
database. Data could be queried by patient/sample details
(such as related histology, cellular component, metasta-
sis site and treatment) and/or patient/sample characteris-
tics (such as menopause status, receptor status, gender and
grade). This dataset is also integrated with the gene dataset.
Links to the BCCTB Sample Finder are achieved through
this layer.
Quick search
We also provide a quick search for users to mine publica-
tions in the database where their particular gene of interest
is reported using standard gene symbols. The quick search
box has an autocomplete function. The results contain a
summary of the studies reporting a link between the search
term and breast cancer. This allows users to quickly val-
idate or check the current knowledge about the role of a
gene/protein in breast cancer.
Association with the BCC Tissue Bank Sample Finder
Users of the BCCTB Sample Finder (described elsewhere,
manuscript in peer-review) automatically access BCCTBbp.
While assessing the availability of tissues of interest for their
particular project, the Tissue Bank user will simultaneously
see any literature currently available in BCCTBbp on simi-
lar sample sets (Figure 2). The BCCTBbp uses an enhanced
controlled vocabulary from the BCCTB, which only has
terms for the tissue types that are represented in the bank.
However an internal mapping has been created to maximise
the cross-querying of the two resources. For example, the
Sample Finder was used to retrieve ILC samples available
from BCCTB (Figure 2). Clicking on the bioinformatics de-
tails reveals 18 published studies involving this type of sam-
ple, allowing researchers to quickly identify studies similar
to their research interests (Figure 2). Further mining of ILC
data through BCCTBbp directly is presented in Figure 1.
Data connectivity and interoperability
BCCTBbp is also a DAS server (8) and can be used in
other resources or browsers such as Ensembl GeneView
(9) using the GeneDAS protocol. Access is also possi-
ble via web services through third party software tools
that have been made compatible with BioMart resources
(5), such as programmatic access via BioMart APIs,
R/BioConductor packages (10), Galaxy (11) and Cy-
toscape (12). The database is also accessible as a LinkOut
resource from NCBI EntrezGene (13) and the International
Cancer Genome Consortium data portal (14) (release 13).
ANALYTICAL LAYER
The BCCTBbp additionally contains an integrated analyt-
ical tools resource for the interactive assessment of BC-
CTBbp datasets. This has been integrated within the web in-
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Figure 3. Analytical layer and integrated modules. The analytical tools can be accessed from the menu bar at http://bioinformatics.breastcancertissuebank.
org/analysisTools.html. First one could choose the dataset of interest by pressing the radio-buttons to the left of the dataset title. For this example we are
selecting the dataset from (A). Ivshina et al. as it has the largest sample size and contains survival information (http://bioinformatics.breastcancertissuebank.
org/analysisTools.html?dset=Ivshina). (B) Selecting the ‘Transcriptomics Analysis’ option, and giving a gene name, MELK in this example, will result in
the analysis of MELK gene (Entrez Gene ID: 9833) expression per molecular subtype (C) Returning to the analysis screen and selecting ‘Survival analysis
by gene of interest’ for the MELK gene will produce the survival figure for two sub-groups automatically selected by the median value of MELK gene
expression. Risk group assignment is presented with RG1 (black) for low expression and RG2 (red) for high expression of MELK.
terface and facilitates tailored analysis of key datasets based
on individual user interests allowing users to simply and ef-
ficiently pose questions not addressed in the original publi-
cations. This greatly expands the utility of the BCCTBbp.
Four analysis categories can be performed: Molecular
Classification; Tumour Purity; Gene Expression; and Sur-
vival. Each of the included dataset samples can be classi-
fied based on the PAM50 set of markers (15) or the hor-
monal receptor status can be inferred from the transcrip-
tome using the MCLUST R package (http://cran.r-project.
org/web/packages/mclust/). Cancer samples frequently con-
tain a small proportion of normal adjacent tissue that might
confuse sample analysis. A method to infer sample can-
cer purity is implemented using ESTIMATE (16). Gene
expression plots can be obtained for a gene of interest
(Figure 3). Finally, for datasets that contain patient sur-
vival information, survival analysis can be performed us-
ing the ‘survival’ package in R (http://cran.r-project.org/
web/packages/survival/). Two modes are available, survival
based on sample sub-groups within the dataset or survival
based on the expression value of a gene of interest. In the
gene-based survival analysis, two classes of gene expression
values (high and low) are determined based on the median
expression value (Figure 3).
ADDITIONAL FEATURES
Data upload
To engage the wider research community, we have created
provision for researchers to upload their own datasets of
interest. The upload function is kept simple and requires
a minimal set of information relevant to the study. For ex-
ample, the user should provide information on the publica-
tion describing the dataset (e.g. title, authors and journal)
as well as information on the experiment that originated the
results, namely technology and biological comparison. Ex-
tra fields are also provided if the user wants to upload more
details about the experiment. Finally, the user needs to up-
load the findings (e.g. gene/protein regulation data) in a pre-
formatted excel file. Once submitted, the BCCTBbp team
checks the uploaded data before inclusion in the database.
Users are asked to provide an email address for contact in
case of issues/questions regarding the submission.
Documentation
A basic user guide has been provided that describes the
features and functionalities of the website. The guide in-
cludes step-by-step instructions to guide users through the
advanced features of the website such as performing com-
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plex queries through MartView interface or using the anal-
ysis tools. It also includes detailed instructions on accessing
the portal data from external resources.
FUTURE DIRECTIONS
BCCTBbp aims to support the Tissue Bank mission and
maximise its return for the scientific community. Going for-
ward, the portal will hold the experimental results generated
on samples from the Tissue Bank. As data on the specific tis-
sues in the bank are collated and returned to the bank, BC-
CTBbp will make this available to researchers thus building
a valuable resource of information on the tissues in BCCTB
that will save repetition of experiments and expand scien-
tific knowledge. While focusing on increasing the data con-
tent, new graphical and analytical features will also be im-
plemented to accommodate new data types and technolo-
gies.
New technologies for translational research are increas-
ingly being developed to bridge the gap between clinical and
research data. Developments in platforms such as Trans-
MART (http://transmartfoundation.org/) are being closely
monitored and will be assessed in future releases of BC-
CTBbp to move the platform from being a bioinformatics
resource to providing a complete infrastructure for transla-
tional research.
While the literature and analytical components of the
bioinformatics portal are undoubtedly valuable stand-alone
resources, the full potential of the unique relationship be-
tween BCCTB and BCCTBbp will only become apparent
in the upcoming years as the volume of valuable data about
the samples available from the Tissue Bank accumulates.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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